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The origin of autoantibodies  in  systemic lupus erythematosus (SLE) 1 is  un- 
known, and the mechanism that accounts for the diversity of serological abnor- 
malities in this disease is poorly understood. Clues that may clarify these problems 
have been obtained by the use of hybridomas that produce monoclonal lupus 
autoantibodies, which permit analyses of individual antibodies (1-4). Most mon- 
oclonal examples of anti-DNA antibodies, the dominant type of lupus autoanti- 
body, bind to different polynucleotides of varying base composition (5-8). These 
antibodies may thus recognize a common feature of the sugar-phosphate back- 
bone of nucleic acids, and the diverse reactions of such antibodies with nucleic 
acids presumably depend on particular spacings of phosphodiester groups in the 
backbone.  Phosphodiester groups occur in both polynucleotides and phospho- 
lipids, which can account for the ability of some monoclonal (8, 9) and serum- 
derived  (10)  lupus  autoantibodies  to  bind  to  both  species  of molecules.  In 
principle, therefore, a  single lupus antoantibody could produce serological re- 
actions  with  a  variety  of test  antigens.  Indeed,  individual  monoclonal  lupus 
autoantibodies have been shown not only to bind to multiple nucleic acids, but 
also  to  produce  the  fluorescent antinuclear  reaction,  behave  like  the  lupus 
anticoagulant, and react with cardiolipin, the antigen used in serological tests for 
syphilis (9). 
In  the  present  experiments we  have  continued our  studies  of monoclonal 
human lupus autoantibodies with an analysis of their idiotypes. The sharing of 
idiotypes by autoantibodies obtained from different patients would suggest that 
they are products of germ line genes that are dispersed throughout the popula- 
tion. We used three antiidiotypic antibodies to test 60 human anti-DNA mono- 
clonal antibodies derived from seven SLE patients and found a substantial degree 
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of idiotypic sharing not only among autoantibodies  from the  same patient,  but 
also among autoantibodies from unrelated patients. 
Materials and  Methods 
Human  Monoclonal A~ti-DNA  Antibodies.  The clinical data of the seven patients with 
SLE whose lymphocytes were used for the preparation of human-human hybridomas (8) 
and  the  production  and  affinity  purification  of the  monoclonal  antibodies  have  been 
described previously (8,  11). All the monoclonal antibodies were IgM-k and were initially 
identified as anti-single-stranded (ss) DNA antibodies.  Subsequent  analyses also demon- 
strated their ability to bind to other polynucleotides (e.g., poly(dT) and poly(I)) and in 
some cases to cardiolipin (8). The antigen binding characteristics of the two monoclonal 
antibodies (B-16/6 and A-32/15) that were used to produce the antiidiotype antibodies 
are depicted in  Fig.  1. These antibodies were derived from two unrelated patients. The 
source of the monoclonal antibodies is indicated  by the prefix A,  B,  C,  D,  E,  F, or G, 
which denote the seven patients. 
Production of Antiidioh'pe Antibodies.  Two antiidiotype sera (anti-32/15/R and anti-16/ 
6/R)  were  prepared  by  monthly  immunization  of rabbits  according  to  the  multiple 
intraderma] injection method of Vaitukaitis (12). For the first and second immunizations 
the monoclonal antibody was mixed with an equal volume of complete Freund's adjuvant 
(Difco  Laboratories  Inc.,  Detroit,  MI).  Thereafter,  the  immunizations  were  given  in 
incomplete Freund's adjuvant (Difco). The rabbits were bled after 3 mo and  1 wk after 
each booster. Their sera were rendered idiotype specific by absorption on a human IgG- 
IgM Sepharose column. The rabbit sera were pumped through the Sepharose column in 
the cold for 18 h at a rate of 10-20 ml/h, which is equivalent to nine separate absorptions. 
The absorbed sera were tested by ELISA (8,  11) and RIA (5) methods for the presence 
of antiidiotypic activity by their ability to bind to the immunizing idiotype and a panel of 
human monoclonal and polyclonal immunoglobulins.  A  monoclonal mouse antiidiotype 
antibody (anti-32/15/M)  was obtained from a  hybridoma that was produced by fusing 
the  nonsecreting  myeloma cell  line  (P3x63-Ag.653)  with  spleen  cells  from a  BALB/c 
mouse that was immunized with the monoclonal anti-DNA antibody A-32/15 according 
to a previously described method (1). 
Inhibition of Binding of Monoclonal Anti-DNA Antibodies to Antiidiotype Antibodies by Polynu- 
cleotides.  Antiidiotype sera were diluted  1:500 in 0.05  M borate buffer, pH 8, and  150 
ul was'added to the wells of polystyrene plates, which were incubated overnight at 4°C. 
The antiidiotype coated plates were then  washed three  times with  PBS containing  1% 
Tween-20 (TPBS) and then with PBS.  Dilutions of ssDNA (0.39-50 #g/ml) or poly(dT) 
(0.21-27  ug/ml) were  incubated  with  1.0  ug of B-16/6  or A-32/15  monoclonal anti- 
DNA  antibody  for  1  h  at  37°C  and  then  overnight  at  4°C.  The  mixture  was  then 
transferred to the antiidiotype-coated plates and incubated for 2 h at 23°C. After three 
washes with TPBS and PBS,  150 #1 of goat anti-human immunoglobulin conjugated to 
alkalin&phosphatase was added and the plates were incubated overnight at 4°C.  Deter- 
mination of bound alkaline phosphatase was performed as described previously (11). 
Inhibition of Binding  of Monoclonal anti-DNA  antibodies to ssDNA by Antiidiotype Antibod- 
ies.  Dilutions of monoclonal anti-DNA antibodies (100 •1)  in 0.1  M potassium phosphate 
buffer containing 0.1% bovine serum albumin and 0.01% Tween-20 buffer (TKP) were 
mixed  with  100  #1  of antiidiotype antisera  or,  as a  control,  normal  rabbit  serum  and 
incubated in glass tubes for I h at 37 °C. The mixture (75/A) was transferred to polystyrene 
tubes coated with ssDNA and incubated for 1 h at 37°C.  The tubes were washed three 
times with TKP and 100 #1 of ~25I-affinity-purified  rabbit anti-human IgM (100,000 cpm) 
was added.  After overnight incubation at 4°C  the tubes were washed three times with 
buffer and bound ~5I was measured in a y-counter. 
Inhibition of Binding of Antiidiotype Antibodies to Their Homologous Idiotypes By Monoclonal 
A~Ttibodies.  Affinity-purified monoclonal anti-DNA antibody was diluted in 0.05 M borate 
buffer, pH 8.6. Concentrations of monoclonal antibody that produced 50% of maximum 
binding to the homologous antiidiotype antibody were incubated in wells of polystyrene 720  IDIOTYPIC CROSS-REACTIONS  OF  LUPUS  AUTOANTIBODIES 
[  B- 16/6 ] 
I00 
¢3 
0 
i0 -! 
\\  ..- 
~\  \  POLY  d  T 
\7 
ONA 
1  I  I  I 
i0  -!  i0 o  I01  I0 | 
nM POLYNUCLEOTIDE COMPETITOR (PHOSPHATE) 
[ A - 32/15  ] 
IOC  ~,  __  ,~----0~-6.~  _~  __6  . .~-.--~ 
1  I  I  1 
i0 -2  i0 q  I0 o  IO t  I0 | 
nM POLYNUCLEOTIDE COMPETITOR (PHOSPHATE) 
FIcuRE  ].  Ligand-binding characteristics of A-32/] 5 and B- 16/6, the two monoclonal lupus 
autoantibodies that  were  used  to  prepare  the  antiidiotype antibodies  employed  in these 
experiments.  The autoantibodies were incubated with increasing amounts of various polynu- 
cleotides and then tested for residual binding to ssDNA (solid phase) by means of an ELISA 
method (8). Abscissa shows amount of competing polynucleotide and ordinate gives inhibition 
of the binding  of the antibody to ssDNA. 
plates overnight at 4°C. The idiotype coated plates were washed three times with TPBS 
and PBS. Equal amounts of diluted antiidiotype antibody and dilutions of the competing 
monoclonal anti-DNA antibodies were incubated for 2 h at 23°C, and then applied to the 
idiotype-coated plates for  1 h.  After three washes with TPBS and PBS,  150 ul of goat 
anti-rabbit or rabbit anti-mouse immunoglobulin  (for anti-32/15/M) conjugated to alka- SHOENFELD  ET  AL.  721 
line phosphatase were added and the plates were incubated overnight at 4°C. The final 
steps of the assay were identical to those described above. 
An analogous competitive assay was also carried out by RIA. Affinity-purified idiotypes 
were coated on polystyrene test tubes at a concentration of 0.25 #g/ml in 0.05 M sodium 
borate buffer, pH 8.6. Rabbit antiidiotype antisera were used at dilutions that achieved 
50% of the maximum binding of antiidiotype to tubes coated with homologous idiotype. 
This dilution of antiidiotype antiserum in TKP (100 #1) was mixed with 100 ~tl of various 
concentrations of affinity-purified competing monoclonal anti-DNA antibodies and incu- 
bated in glass tubes for 1 h at 37°C. The mixture (75 tzl) was then transferred to idiotype- 
coated tubes and allowed to incubate for 1 h at 37°C. The tubes were washed three times 
with TKP and 100 #! of ~SI-affinity-purified goat anti-rabbit immunoglobulin was added 
and the tubes were incubated overnight at 4°C. The tubes were then washed three times 
and bound 1~5I was measured. 
Results 
Characteristics  of the  Antiidiotvpe  Antibodies.  Two  antiidiotype  antisera  were 
produced by immunization of rabbits with the monoclonal anti-DNA antibodies 
A-32/15 and B-16/6. The antiidiotype antibodies, designated anti-16/6/R  and 
anti-32/15/R,  were  used in  solid phase  (RIA  or ELISA) assays in dilutions of 
1:25,000 and  1:12,000, respectively. The monoclonal antiidiotype (anti-32/15/ 
M) was affinity purified on a goat-anti-mouse immunoglobulin Sepharose column 
and used in a  dilution of 1:6,000  from a  stock solution containing 300/~g/ml. 
Comparable  results  were  obtained  with  these  antibodies  in  independent  tests 
conducted in  Boston  (ELISA) and  Montreal  (RIA).  For simplicity,  the  results 
reported are  those  of ELISA assays,  except where  mentioned  otherwise.  The 
reaction of each antiidiotype antibody with its idiotype was 50% inhibited by 4- 
15  ng  of the  homologous  idiotype  in  competitive assays  (see  below).  In  both 
direct binding (Table I) and competition assays (see Fig.  3), none of the antiidi- 
otype antibodies reacted with two pools of affinity-purified IgM obtained from 
over 20  normal  human  donors,  with  five myeloma or Waldenstrom's  proteins 
(both K and ;k) or with the IgGk produced by the GM 4672 lymphoblastoid cell 
line that was used for the fusions. In addition, none of the antiidiotype antibodies 
bound to ssDNA, dsDNA, or other polynucleotides (data not shown). 
To  test  whether  the antiidiotype antibodies  bound  to a  structure  within  or 
near the antigen-binding sites of the autoantibodies, we determined whether the 
TABLE  I 
Optical Density, (A4o.O Readings of Direct Binding Assays 
Test immunoglobulin 
Antiidiotype 
Anti- 16/6/R  Anti-32-15/R  Anti-32/15/M 
Pooled normal IgM  0.02  0.06  0.04 
A-32/15  --  1.00  0.34 
B-16/6  1.00  --  -- 
Buffer only  0.01  0.01  0.01 
Optical density (A405) readings of direct binding assays of the three antiidiotype reagents used in the 
present experiments. The test immunoglobulins (1 #g/ml) were bound to polystyrene wells and then 
incubated with a 1:1,600 dilution of the antiidiotypes. Bound antiidiotype was detected with alkaline 
phosphatase labeled goat anti-rabbit (or anti-mouse for anti-32/15/M) antisera. The final dilutions 
in which the antiidiotypes were used for the competitive assays shown in Table II and Figs. 3 and 4 
were: 1:25,000 (anti-16/6/R), 1:12,000 (anti-32/15/R) and 1:6,000 (anti-32/15/M). 722  IDIOTYPIC  CROSS-REACTIONS  OF  LUPUS  AUTOANTIBODIES 
idiotype-antiidiotype reactions  could  be  inhibited  by  prior  incubation  of the 
monoclonal autoantibodies with polynucleotides. Fig. 2 (left) depicts the inhibition 
of binding of A-32/15 to anti-32/15/M  coated plates by poly(dT), poly(I), and 
ssDNA;  50%  inhibition  was achieved with  0.13  ug poly(dT) and  with  7.5  #g 
poly(I). By contrast,  up to 50 #g ssDNA  failed to cause 50%  inhibition  of the 
binding of A-32/15 to anti-32/15/M coated plates. The basis for the plateau in 
the competition of the monoclonal anti-idiotype antibody by ssDNA is not clear. 
The binding of A-32/15 to anti-32/15/R was 50% inhibited by 1.56 #g ssDNA, 
2.0 #g poly(dT), and 3.8 #g poly(I) (Fig.  2,  right).  Anti-16/6/R,  however, was 
50% inhibited only by poly(I) (23 ug). 
Cross-rec~ctio,s  of Monoclonal  Autoantibody  Idiotypes.  Multiple  cross  reactions 
were found among the monoclonal autoantibodies with the three antiidiotype 
reagents. Fig. 3 shows representative competition assays in which anti-16/6/R, 
anti-32/15/R  and  anti-32/15/M  were  employed.  The  results  were  selected 
from assays of 60  monoclonal anti-DNA antibodies to demonstrate cross-reac- 
tions that were observed with autoantibodies from the same patient, as well as 
with antibodies from unrelated patients (Table II). In Fig. 3A, for instance, the 
reaction of anti- 16/6/R with B- 16/6 was inhibited by monoclonal autoantibodies 
from  patients  A,  B,  and  E.  The  similar  contours  of the  competition  curves 
observed with monoclonal immunoglobulins A-12/6 and B-16/5  suggests that 
anti-16/6/R  detected similar idiotypic structures in  these two autoantibodies. 
Fig.  3B demonstrates examples of competition curves obtained with anti-32/ 
15/R  (derived from patient  A).  Autoantibodies B-15/3  and  F-101  generated 
almost parallel competition curves in this system, an indication that they possess 
closely related  idiotypes.  Examples  of competition  curves  obtained  with  the 
monoclonal antiidiotype, anti-32/15/M, are given in Fig. 3C. Here, the strong 
cross-reaction with F-100 is notable; 32 ng of this antibody was required for 50% 
inhibition,  a  value comparable to  the  15  ng required by A-32/15  itself. The 
reactions of a single monoclonal autoantibody, A-21/37,  with the three antiidi- 
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FIGURE  2.  Inhibition  of idiotype/antiidiotype  binding  by  polynucleotides.  The  idiotype 
(monoclonal antoantibody) was incubated with increasing amounts of polynucleotide and then 
tested  for residual  binding  to the corresponding antiidiotype  (solid phase)  by  means of an 
ELISA method. 
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FIGURE 3.  Representative solid phase  competition assays  of monoclonal autoantibody  idi- 
otypes.  Increasing  amounts  of  competing  monoclona]  antibody  were  incubated  with  the 
indicated antiidiotype reagent and the mixture was added  to wells of polystyrene microtiter 
plates that  were coated with the homologous monoclonal autoantibody.  Bound antiidiotype 
was detected with goat anti-rabbit (for anti-16/6/R and anti-32/15/R) or rabbit anti-mouse 
(for anti-32/15/M) immunoglobulin by an ELISA method. (.4) anti-16/6/R with B-16/6 on 
the solid phase; (B) anti-32/15/R with A-32/15 on the solid phase; (C) anti-32/15/M with A- 
32/15  on  the solid  phase;  (D)  reactions  of A-21/37  in  the  three  assay  systems.  "Control 
immunoglobulins" in panels A-C consist of two pools of affinity-purified IgM from over 20 
normal persons,  5  myeloma and  Waldenstrom's proteins and the IgG produced by the GM 
4672 cell line. None of these immunoglobulins competed in the assays and results for all of 
them is shown by a single symbol. 
otype reagents is shown in Fig. 3 D. This antibody is one of 15 that cross-reacted 
with all three reagents. Table I lists the results for all 60 monoclonal autoanti- 
bodies,  and  in  Fig.  4  the data are arranged  to  show  the order in  which the 
monoclonal autoantibodies cross-reacted in terms of the amount of immunoglob- 
ulin required for 50% inhibition. Of the 60 monoclonal autoantibodies, 20 failed 
to react with any of the three antiidiotype antibodies. Of the remaining 40,  30, 
derived from patients A, B, C, and E, reacted with anti-16/6/R  (Fig. 4A); 22, 
from patients A, B, and C, reacted with anti-32/15/R  (Fig. 4B); and 26, from 
patients A, B, D, E, F, and G, reacted with anti-32/15/M (Fig. 4C). Comparison 
of these groups demonstrates that the patterns of cross-reactivity with anti-32/ 
15/M and anti-32/15/R  differed. Another noteworthy feature is that 6 mono- 724  1DIOTYP1C  CROSS-REACTIONS  OF  LUPUS  AUTOANTIBODIES 
TABLE  II 
Results of Competitive bnmunoassays 
Monoclonal antibody  Anti-16/6/R  Anti-32/15/R  Anti-32/15/M 
A-1/9b  72  640  88 
A-1/13b  4  15  98 
A-1/17  3  20  NI 
A-1/43  9  NI  NI 
A-3/1  50  120  NI 
A-9/I  NI  NI  NI 
A-12/6  3  100  900 
A-12/lla  3  700  54 
A-12/33  3  110  65 
A-18/2  6  100  NI 
A-18/7  3  250  25 
A-18/8  6  NI  NI 
A-18/9  11  NI  NI 
A-18/17  NI  NI  NI 
A-21/28  520  22  245 
A-21/29  87  22  13 
A-21/37  56  140  37 
A-30/17  100  190  NI 
A-32/9  50  8  6 
A-32/15  130  13  15 
B-4/5  NI  250  40 
B-4/7  6  NI  25O 
B-4/8  NI  NI  265 
B-11/32  170  800  310 
B-15/12a  500  540  680 
B-15/13  54  320  NI 
B-15/14  74  23  80 
B-16/5  48  750  NI 
B-16/6  4  440  250 
C-4/1  NI  N1  N1 
C-7/3  800  NI  NI 
C-7/4  NI  NI  NI 
C-7/9  NI  NI  NI 
C-7/8  NI  N1  NI 
C-12/1  70  NI  NI 
C-12/2  NI  NI  NI 
C-12/4  NI  N1  NI 
C-12/9  31  10  NI 
C-12/2  NI  NI  NI 
D-7/9  NI  NI  NI 
D-14/10  NI  N1  N1 
D-20/5  NI  N1  195 
D-36/12  NI  NI  NI 
E-7/1  335  NI  960 
E-14/10  120  NI  N[ 
E-19/10  300  NI  NI SHOENFELD  ET  AL. 
TABLr II (Continued) 
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Monoclonal Antibody  Anti-16/6/R  Anti-32/15/R  Anti-32/15/M 
F-IO0  NI  NI  32 
F-IO0.1  NI  NI  NI 
F-103  NI  NI  NI 
F-103.1  NI  NI  NI 
F-112.2  NI  NI  NI 
F-113.3  NI  NI  370 
F-121  NI  NI  195 
F-128  N|  NI  440 
F-134  NI  NI  300 
F-134.1  NI  NI  NI 
F-134.2  NI  NI  NI 
G-600  NI  NI  NI 
G-601  NI  NI  13 
G-604  NI  NI  NI 
Numerical values are the ng idiotype competitor required for 50% inhibition of 
the homologous idiotype-antiidiotype reaction. NI, not inhibited by 1,000 ng. 
cional  antibodies  from  patient  A  reacted  at  least  as  well  with  anti-16/6/R 
(derived from patient B) as B-16/6 itself (Fig. 4A). 
Idiotypic cross-reactivity was also demonstrated by inhibition of the binding of 
monoclonal anti-DNA antibodies to ssDNA by anti-32/15/R  or anti-16/6/R. 
Five monoclonal antibodies were chosen for this purpose (Fig. 5). The ability of 
the antiidiotype antibodies to inhibit reactions of the autoantibodies with ssDNA 
was consistent with the ability of polynucleotides to inhibit idiotype binding to 
antiidiotype (Fig. 2), and again indicates that the antiidiotype antibodies reacted 
with determinants in  the autoantibodies  that  are required for polynucleotide 
binding.  Nevertheless, the two test systems revealed differences: even though 
anti-16/6/R  was able  to  block  the binding  of both  B-16/6  and  A-1/13b  to 
ssDNA  (Fig.  5),  the binding  of anti-16/6/R  to  B-16/6  was  not inhibited by 
ssDNA. 
Discussion 
We have demonstrated that IgM monoclonal anti-DNA autoantibodies derived 
from seven  unrelated patients  with  SLE  possess  cross-reactive idiotypes.  The 
antiidiotype antibodies  that  detected these  cross-reactions were produced by 
immunization  of animals  with  IgM  monoclonal antibodies  derived from  two 
unrelated patients.  It is unlikely that the antiidiotype reagents reacted with the 
Fc portion of the autoantibodies, or that they were antiallotypic antibodies, since 
they did not react with pooled immunoglobulins obtained from normal persons, 
nor did they bind to monoclonal immunoglobulins from patients with myeloma 
and  macroglobulinemia.  Instead,  the  antiidiotype antibodies  seemed to  react 
with structures in or near the antigen combining sites of the monoclonal auto- 
antibodies.  This  conclusion  rests  on  the  demonstration  that  binding  of the 
monoclonal idiotype to its homologous antiidiotype antibody was inhibited by 
autoantigen (polynucleotide). The reaction of anti-32/15/M  with A-32/15 was 726  IDIOTYPIC CROSS-REACTIONS  OF  LUPUS  AUTOANTIBODIES 
F ~  Anti-52/15/Id 
log  ng  for  50% Inhibition 
0  I  2  3 
IIIIlllllllllllJll  Illllll|l  III  I 
Anti-16/6/R 
A  1 
A 
B  L 
A  L 
A  L 
°  L 
A 
A 
F" 
°  L 
A 
°  1  A 
A 
v  ll 
B 
F  I 
v  I 
e  I 
e~  i] 
A  I  An?i-52/15/R 
A 
A 
A  A  I 
A 
B 
"  t  A 
A  I 
A  I 
A  I 
A  I 
"  I  B 
1 
a  I  1-  A  I 
L__  °  t 
A~  )  C:  j 
FIGURE 4.  Results  of the solid phase competitive assays shown in Fig. :3 for all cross-reacting 
monoclonal autoantibodies,  arranged in order of the amount of autoantibody  required  for 
50~ inhibition of the homologous system. The black bar indicates the homologous autoanti- 
body (e.g., B-16/6 for anti-16/6/R). Letters at the left of each bar denote the patient from 
whom the monoclonal autoantibody  was derived. (A) anti-16/6/R with B-I 6/6 on the solid 
phase; 30/60 monoclonal antibodies, from patients A, B, C, and E, cross-reacted. (B) anti-32/ 
15/R with A-32/15 on the solid phase; 22/60 monoclonal antibodies, from patients A, B, 
and C, cross-reacted. (C) anti-32/lfi/M  with A-32/15/M  on the solid phase; 25/60 mono- 
clonal antibodies, from patients A, B, D, E, F, and G, cross reacted. 
almost  completely  inhibited  by  poly(dT)  (0.13  #g  gave  50%  inhibition)  and 
poly(I) (3.8  #g gave 50%  inhibition),  but <50%  inhibition  occurred with  50 #g 
ssDNA  (Fig.  2).  Nevertheless,  A-32/15  bound  to  all  three  polynucleotides,  in 
the order poly(dT) >  ssDNA >  poly(I) (Fig.  1). It thus seems that the monoclonal 
antiidiotype  reacts  with  a  relatively small  "patch"  in  the  variable region  of A- 
32/15  that  is required  for binding to poly(dT) and  poly(I), but  not  to ssDNA. 
The  reaction  of anti-32/15/R  with  A-32/15,  by contrast,  was inhibited  by all 
three  nucleic  acids (Fig.  2B), albeit in a  different order  than  they bound  to  A- 
32/15. Therefore, anti-32/15/M  and anti-32/15/R  probably react with differ- 
ent idiotypic epitopes in A-32/15.  The inhibition  results with anti-16/6/R  are 
also of interest. The autoantibody B-16/6 bound to poly(I), poly(dT), and ssDNA 
(Fig.  1), yet its reaction with anti-16/6/R  was inhibited only by poly(I). Even so, 
anti-16/6/R  was able to block the binding of B-16/6  to ssDNA (Fig.  5).  These SHOENFELD  ET  AL.  727 
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FIGURE 5.  Inhibition of binding of idiotype (monoclonal autoantibody) to ssDNA by antiidi- 
otype serum.  Idiotype was added to increasing amounts of antiidiotype and the mixture was 
transferred to tubes coated  with ssDNA.  Bound idiotype was detected with  l~SI-rabbit anti- 
human IgM, Numbers in parenthesis are the amounts of idiotype required for 50% inhibition 
in the assay for idiotypic cross-reaction shown in Fig. 3; NI, not inhibitory in that assay. Note 
that anti-32/15/R completely blocked the binding of A-32/15 to ssDNA (left)  and that anti- 
16/6/R caused 90% inhibition of the binding of B-16/6 to ssDNA (right). 
disparate results  may reflect differences in  the sensitivities of the various test 
systems,  as  well  as  the  participation  of different  subsites  in  combining  with 
antiidiotype or polynucleotides. 
Of the 60 monoclonal autoantibodies we tested, 20 failed to react with any of 
the antiidiotypic reagents. These 20 antibodies had no binding properties with 
polynucleotides or cardiolipin that distinguished them from the other autoanti- 
bodies.  Indeed, we found no relationship between antigen binding properties 
and  idiotypic  cross-reactions  in  the  entire  group  (data  not  shown).  Of  the 
remaining 40 autoantibodies,  15 cross-reacted with one antiidiotype, 10 reacted 
with two antiidiotypes, and 15 cross-reacted with three antiidiotypes. The latter 
15  presumably  contain  at  least  three  serologically distinct  idiotypic  markers 
because anti- 16/6/R, anti-32/15/R,  and anti-32/15/M  reacted with different 
variable region structures, as judged by the results of polynucleotide and idiotype 
inhibition studies.(Figs. 2 and 4). Moreover, the observation that nine monoclonal 
autoantibodies derived from five patients reacted exclusively with anti-32~15~ 
M (Table I) suggests that this reagent detected a unique idiotypic determinant. 
The  ability  of the  monoclonal  antiidiotype anti-32/15/M  to  detect  a  cross- 
reactive idiotype in autoantibodies from 6/7  patients is noteworthy because it 
indicates that a particular family of epitopes has a wide distribution among lupus 
autoantibody idiotypes. A similar result was recently reported by Solomon et al. 
(13) with a monoclonal antiidiotype obtained by immunization of a mouse with 
partially purified anti-DNA antibodies from the serum of a  patient with SLE. 
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Moreover, it reacted with anti-double stranded (ds)  DNA antibodies of all  IgG 
classes. Their antiidiotype, unlike our reagents, is not directed against the antigen 
binding  site  because ds  DNA  does  not  inhibit  its  reaction with  anti-ds  DNA 
antibodies, nor does the antiidiotype inhibit binding of anti-DNA antibodies to 
DNA. The reagent produced by Solomon et al. (13) can detect a cross-reactive 
idiotype in the serum of lupus patients with active clinical disease but without 
detectable  anti-ds  DNA  antibodies.  Such  antiidiotypes  may  thus  find  useful 
clinical applications. 
Anti-16/6/R  reacted  with  31  monoclonal  autoantibodies  derived  from  4 
patients  (A,  B,  C,  and  E);  anti-32/15/R  reacted  with  23  antibodies  from  3 
patients  (A,  B,  and  C)  and anti-32/15/M  reacted with  26  antibodies from 6 
patients (Fig. 4). The occurrence of related idiotypic families in lupus autoanti- 
bodies from the seven patients is thus notable. These results support the hypoth- 
esis that the anti-DNA antibodies of SLE have a  restricted diversity. They are 
also  concordant  with  the  above-mentioned  restrictions  that  were  found  by 
analyses of the ligand binding properties of monoclonal lupus autoantibodies. 
Nevertheless, structural studies of the monoclonal autoantibodies, now in prog- 
ress, will be required to define more precisely the basis of the idiotypic related- 
ness.  Such  studies are  important  because amino acid sequence analyses have 
demonstrated that considerable structural variations can exist even when mon- 
oclonal immunoglobulins possess closely related idiotypic markers (14). 
Substantial idiotypic cross-reactivity occurs among monoclonal lupus autoanti- 
bodies derived from either (NZB X NZW)F1 (15,  16) or MRL-Ipr/lpr mice (17), 
which may be due to their origins from inbred strains. Even so, Datta et al. (18) 
recently found that NZB mice can produce immunoglobulins that share idiotypes 
with a monoclonal anti-DNA antibody derived from genetically unrelated MRL- 
Ipr/lpr mice. Cross-reacting idiotypes have also been reported with other human 
autoantibodies,  including  IgM  cold agglutinins  (19),  rheumatoid factors (20), 
mixed cryoglobulins (21),  anti-acetylcholine receptor antibodies from patients 
with  myasthenia  gravis  (22),  and  cerebrospinal  fluid  immunogiobulins  from 
patients with multiple sclerosis (23).  In all these cases the autoantibodies were 
obtained from genetically unrelated persons. 
Whether anti-DNA autoantibodies, or autoantibodies with other specificities, 
have any more idiotypic cross-reactions than other antibodies formed against a 
foreign antigen is not known. This possibility has not been extensively studied, 
but Kennedy and Dreesman (24) reported that antiidiotype sera against purified 
anti-hepatitis B surface antigen (HBs) from two persons recognized an idiotype 
in purified anti-HBs from three additional individuals as well as in anti-HBs sera 
from six  hemophiliacs. Thus, antibodies formed by humans in response to an 
infectious  virus  have  shared  idiotypes,  an  indication  that  extensively shared 
idiotypes are not unique to autoantibodies in man. 
Public idiotypic markers of the type we found seem to be products of germline 
variable region genes (25).  In the mouse, idiotypes of lupus autoantibodies are 
not confined to lupus-prone mice, but can also be produced by B lymphocytes 
of normal animals (18). This finding suggests that genes that encode the variable 
regions of lupus autoantibodies may exist in all mice, but only when there is a 
predisposition to SLE are they expressed. Whether this concept applies to human SHOENFELD  ET  AL.  729 
SLE  can  now  be  tested  because  the  appropriate  antiidiotypic  reagents  are 
available.  Finally, the occurrence  of cross-reactive idiotypes in  lupus autoanti- 
bodies, especially those that are detectable by a monoclonal antiidiotypic reagent, 
may render feasible the possibility of regulating the production of pathogenetic 
autoantibodies with antiidiotype antibodies (26). 
Summary 
Idiotypic cross-reactions were evaluated in  60 polynucleotide-binding mono- 
clonal lupus autoantibodies produced by human-human hybridomas that were 
derived from seven  unrelated patients with  SLE.  Three  antiidiotype reagents 
were prepared  by immunization of rabbits  or a  mouse with monoclona[ auto- 
antibodies from two patients. Binding of the three reagents to their correspond- 
ing idiotypes was inhibited by one or more polynucleotides, an indication that 
the antiidiotypes reacted with the variable regions of the autoantibodies.  Each 
antiidiotype appeared  to  detect  a  different idiotypic determinant.  Of the  60 
monoclonal autoantibodies tested,  40  reacted in  one or more  competitive im- 
munoassays; 15 reacted with one antiidiotype, 10 reacted with two antiidiotypes 
and 15 reacted with three antiidiotypes. A monoclonal antiidiotype reagent cross- 
reacted with autoantibodies from six of the seven patients. The idiotypic cross- 
reactions of immunoglobulins from unrelated patients suggest that the autoanti- 
bodies are derived from related families of germ line genes that are expressed 
by patients with SLE. 
Received  for publication 28 March  1983 and in revised  form 16 May 1983. 
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